Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDA

The FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2p4WWZQ
via IFTTT

0 comments:

Post a Comment